Updates

REF: AGM/INTIMATION/2025-26 Date: August 18, 2026 BSE Limited National Stock Exchange of India Limited 25th Floor, Phiroze Jeejebhoy Towers Exchange Plaza, C-1, Dalal Street, Mumbai 400 001 Block - G Bandra Kurla Complex Bandra (East) Mumbai – 400 051 BSE Code-531146 NSE Code: MEDICAMEQ Sub. : Intimation of Book Closure and Record Date in accordance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Dear Sir/Madam Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, and Section 91 of the Companies Act, 2013, we hereby inform you that the Register of Members and Share Transfer Books of the Company shall remain closed for the purpose of the 33rd Annual General Meeting (“AGM”) of the Company and for determining the entitlement of members to receive the Final Dividend for the Financial Year 2025-26, if declared at the ensuing AGM : Name of Security Type of Book Closure (both days Record Date Purpose Stock Code/ Symbol Security inclusive) for the Exchange From To payment of Dividend BSE Limited 531146 Equity Shares Sunday Saturday Saturday 33rd Annual The National MEDICAMEQ September September September General Stock 20, 2026 26, 19, 2026 Meeting & Exchange of 2026 Payment of India Limited Final Dividend for the Financial Year ended March 31,2026 The Final Dividend has been recommended by the Board of Directors, subject to approval of the members at the ensuing 33rd Annual General Meeting of the Company. The Record Date has been fixed for determining the entitlement of members to receive the Final Dividend, if declared at the AGM, and the dividend shall be paid to those members whose names appear in the Register of Members / records of the Depositories as on the said Record Date, subject to applicable laws. The Company shall accordingly close its Register of Members and Share Transfer Books from 20 September 2026 to 26 September 2026 (both days inclusive) for the aforesaid purposes. This intimation is being submitted to the Stock Exchanges in compliance with the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. You are requested to kindly take the above information on record. Thanking You. Yours Faithfully For Medicamen Biotech Limited Parul Choudhary Company Secretary ACS44157